Related Experiment Videos

Application of chain-based sponge dressing for gunshot wounds in the groin

Weijin Yang1, Junchuan Song1, Yuewen Zhu1

  • 1Department of General Surgery, Dongfang Hospital, Xiamen University, China; Department of General Surgery, The 900th Hospital of Joint Logistics Support Force, PLA, China.

Insights

Chain-based sponge dressing (CSD) significantly reduced hemorrhage time and improved survival rates in a gunshot wound model. This novel dressing offers a promising solution for junctional hemorrhage, demonstrating 100% efficacy in preliminary studies.

Area of Science:

  • Trauma and emergency medicine
  • Surgical hemostasis
  • Wound management

Background:

  • Junctional hemorrhage is a leading cause of death in conflict zones, surpassing extremity hemorrhage.
  • Rapid and effective hemorrhage control is critical in battlefield medicine.
  • The development of advanced hemostatic agents is crucial for improving survival rates.

Purpose of the Study:

  • To evaluate the efficacy of chain-based sponge dressing (CSD) in controlling junctional hemorrhage.
  • To compare the hemostatic performance of CSD against standard gauze in a severe bleeding model.

Main Methods:

  • A gunshot wound model of the femoral artery was created in Bama miniature pigs.
  • Animals were treated with either CSD or standard gauze (SG) for hemostasis.
  • Hemostasis time, success rate, survival time, and secondary damage were compared between groups.

Main Results:

  • CSD achieved hemostasis significantly faster (38.75 s) than SG (630.75 s).
  • CSD demonstrated a 100% hemostasis success rate, compared to 25% for SG.
  • Survival time was significantly longer in the CSD group (120 min) versus the SG group (62.25 min).
  • No secondary damage was observed with CSD application.

Conclusions:

  • CSD is highly effective in achieving rapid hemostasis for junctional hemorrhage in a gunshot wound model.
  • CSD shows potential as a life-saving intervention for penetrating trauma with junctional bleeding.
  • Further clinical research is warranted to confirm the utility of CSD in human patients.
Abstract